Paper17538187
Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice.
Panzer U and 13 others. J Am Soc Nephrol, 2007. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. Papers, record 17538187. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17538187
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nephritis | Major topic |
| Receptors, Chemokine | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Mice | |
| Mice, Inbred C57BL | |
| Receptors, CXCR3 |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41928107 | Application of the nephrotoxic serum nephritis model in glomerulonephritis research. | Mol Med | 2026 | https://conductscience.org/library/papers/41928107 | PubMed |
| 41402748 | APOL1-mediated kidney disease: a narrative review of the lessons learnt from the past 15 years. | BMC Nephrol | 2025 | https://conductscience.org/library/papers/41402748 | PubMed |
| 40485680 | Clinical and Metabolic Signatures of FAM47E-SHROOM3 Haplotypes in a General Population Sample. | Kidney Int Rep | 2025 | https://conductscience.org/library/papers/40485680 | PubMed |
| 40119700 | CXCR3-mediated natural killer cell infiltration exacerbates white matter injury after intracerebral haemorrhage. | Brain | 2025 | https://conductscience.org/library/papers/40119700 | PubMed |
| 39570975 | Immune complex deposition promotes NK cell accumulation in the kidney. | PLoS One | 2024 | https://conductscience.org/library/papers/39570975 | PubMed |
| 39563449 | Semaphorin 5A promotes Th17 differentiation via PI3K-Akt-mTOR in systemic lupus erythematosus. | Arthritis Res Ther | 2024 | https://conductscience.org/library/papers/39563449 | PubMed |
| 38587378 | Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral local tissue-resident and effector memory CD4+ and CD8+ T cells and protects against recurrent genital herpes. | J Virol | 2024 | https://conductscience.org/library/papers/38587378 | PubMed |
| 37968302 | Mucosal-associated invariant T cells contribute to suppression of inflammatory myeloid cells in immune-mediated kidney disease. | Nat Commun | 2023 | https://conductscience.org/library/papers/37968302 | PubMed |
| 37875396 | Identification and Characterization of CD8+ CD27+ CXCR3- T Cell Dysregulation and Progression-Associated Biomarkers in Systemic Lupus Erythematosus. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37875396 | PubMed |
| 36355429 | Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury. | JCI Insight | 2023 | https://conductscience.org/library/papers/36355429 | PubMed |
| 36067633 | Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19. | Comput Biol Med | 2022 | https://conductscience.org/library/papers/36067633 | PubMed |
| 35626662 | Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis. | Cells | 2022 | https://conductscience.org/library/papers/35626662 | PubMed |
| 35250997 | Chemokine-Driven Migration of Pro-Inflammatory CD4+ T Cells in CNS Autoimmune Disease. | Front Immunol | 2022 | https://conductscience.org/library/papers/35250997 | PubMed |
| 34659199 | Pathogenic Roles of CXCL10 in Experimental Autoimmune Prostatitis by Modulating Macrophage Chemotaxis and Cytokine Secretion. | Front Immunol | 2021 | https://conductscience.org/library/papers/34659199 | PubMed |
| 34540858 | The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34540858 | PubMed |
| 33865426 | Chemokines and their receptors: predictors of the therapeutic potential of mesenchymal stromal cells. | J Transl Med | 2021 | https://conductscience.org/library/papers/33865426 | PubMed |
| 33676416 | PD-1 immunobiology in glomerulonephritis and renal cell carcinoma. | BMC Nephrol | 2021 | https://conductscience.org/library/papers/33676416 | PubMed |
| 33598825 | T helper cell trafficking in autoimmune kidney diseases. | Cell Tissue Res | 2021 | https://conductscience.org/library/papers/33598825 | PubMed |
| 32111837 | Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance. | Nat Commun | 2020 | https://conductscience.org/library/papers/32111837 | PubMed |
| 31405951 | A Novel Role for GATA3 in Mesangial Cells in Glomerular Development and Injury. | J Am Soc Nephrol | 2019 | https://conductscience.org/library/papers/31405951 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17538187
GET https://conductscience.org/api/papers/v1/17538187/cited_by?page=2